SCHEMBL2928121

SCHEMBL2928121

N#Cc1ccc(NCCN[N+]23C=C(c4ccc(F)cc4F)N=CC2=NC=N3)nc1

nearest known ligand 0.32

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.32
CCNB2 O95067 1/20 0.32
CDK1 P06493 1/20 0.32
CCNB1 P14635 1/20 0.32
RPS6KB1 P23443 1/20 0.32
CDK2 P24941 1/20 0.32
GSK3A P49840 1/20 0.32
LIMK1 P53667 1/20 0.32
TAOK1 Q7L7X3 1/20 0.32
CCNB3 Q8WWL7 1/20 0.32
SLK Q9H2G2 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
CSNK1G1 Q9HCP0 1/20 0.32
DPP4 P27487 7/20 0.31
DPP7 Q9UHL4 2/20 0.30
DPP8 Q6V1X1 1/20 0.30
IDH1 O75874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4283482 0.99 GSK3B (0.32) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL4282889 0.84 GSK3B (0.45) GSK3BCCNB2CDK1CCNB1RPS6KB1
Hydrochloric Acid SCHEMBL4293352 0.83 ADORA2A (0.31)
SCHEMBL2926625 0.68 CNR1 (0.33) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL2984545 0.67
SCHEMBL2932832 0.66 SCN10A (0.33)
SCHEMBL6638863 0.66 DPP4 (0.53) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL1083877 0.65 EGFR (0.47) GSK3BCLK4
SCHEMBL10269934 0.64 GSK3B (0.36) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL2928118 0.64 GSK3B (0.48) GSK3BCCNB2CDK1CCNB1RPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229392-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE AS GSK3BETA INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2010-09-22 EP disclosed
WO-2009074259-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-06-18 WO disclosed